Bios Fund I, LP

10% OwnerLantern Pharma Inc. (LTRN) · full profile →Form 4 · filed Jun 13, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$208K
Net Open-Market Flow
-$208K
Transactions
15
15 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 12, 2025Sell(S)11K$3.38$37K196K
Jun 12, 2025Sell(S)3K$3.38$10K52K
Jun 12, 2025Sell(S)19K$3.38$63K336K
Jun 12, 2025Sell(S)7K$3.38$22K119K
Jun 12, 2025Sell(S)22K$3.38$73K387K
Jun 11, 2025Sell(S)338$3.40$1K409K
Jun 11, 2025Sell(S)103$3.40$350125K
Jun 11, 2025Sell(S)45$3.40$15355K
Jun 11, 2025Sell(S)171$3.40$581207K
Jun 11, 2025Sell(S)293$3.40$996354K
Jun 10, 2025Sell(S)2$3.40$7125K
Jun 10, 2025Sell(S)5$3.40$17355K
Jun 10, 2025Sell(S)3$3.40$10207K
Jun 10, 2025Sell(S)1$3.40$355K
Jun 10, 2025Sell(S)5$3.40$17409K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-059106) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about LTRN insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001104659-25-059106"
Ask your agent
Use Arkolith to summarize insider buying and selling at Lantern Pharma Inc.
over the last 90 days and cite the filings.